ArticleScientific reports2024
A novel adaptive FOCV algorithm with robust IMRAC control for sustainable and high-efficiency MPPT in standalone PV systems: experimental validation and performance assessment.
Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Current sensorless MPPT method with battery management for PV based single phase standalone system.Scientific reports · 2026Article
- A smart single stage solar battery driven desalination system with hybrid MPPT and optimal control for brackish water treatment.Scientific reports · 2025Article
- A novel global MPPT method based on sooty tern optimization for photovoltaic systems under complex partial shading.Scientific reports · 2025Article
- Hybrid fuzzy logic approach for enhanced MPPT control in PV systems.Scientific reports · 2025Article
- A novel star-nosed mole optimization algorithm applied for MPPT of PV systems.Scientific reports · 2025Article
- Multiple-to-single maximum power point tracking for empowering conventional MPPT algorithms under partial shading conditions.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This paper introduces an innovative, adaptive Fractional Open-Circuit Voltage (FOCV) algorithm combined with a robust Improved Model Reference Adaptive Controller (IMRAC) for Maximum Power Point Tracking (MPPT) in standalone photovoltaic (PV) systems. The proposed two-stage control strategy enhances energy efficiency, simplifies system operation, and addresses limitations in conventional MPPT methods, such as slow convergence, high oscillations, and susceptibility to environmental fluctuations. The first stage dynamically estimates the Maximum Power Point (MPP) voltage using a novel adaptive FOCV method, which eliminates the need for irradiance sensors or physical disconnection of PV modules. This stage incorporates a real-time adjustment of the kv factor based on variations in PV power, ensuring precise voltage estimation. In the second stage, the IMRAC controller ensures accurate tracking of the MPP by adapting swiftly to changes in irradiance and temperature, while minimizing ripple and power loss. Validation of the proposed system was carried out using Processor-in-the-Loop (PIL) testing on an Arduino Due microcontroller, showcasing real-world applicability. Comparative analysis with state-of-the-art MPPT controllers, including P&O-PI, InC-SMC, FLC, and VS P&O Backstepping, demonstrates superior tracking efficiency exceeding 99.49% under EN 50,530 standard test conditions. The system also maintains exceptional performance with minimal efficiency loss across a wide range of temperature and irradiance variations. By combining simplicity, robustness, and sustainability, this work establishes a cutting-edge solution for standalone PV systems, paving the way for more efficient and reliable renewable energy applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.